StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Earnings

Alvotech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q4 FY2025
$173.00M
EPS, Q4 FY2025
–
Latest guidance
Issued
Mar 19, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Alvotech's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 19, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Mar 19, 2026before the open$173.00M––Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025after the close–––Release
Q2 FY2024ended Jun 30, 2024Jul 1, 2024before the open–––Release
Q4 FY2023ended Dec 31, 2023Mar 20, 2024after the close–––Release
Q4 FY2022ended Dec 31, 2022Mar 1, 2023after the close–––Release
Q2 FY2022ended Jun 30, 2022Aug 31, 2022after the close–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Alvotech's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
total revenuesFY2026$650.00M – $700.00M–NewMar 19, 2026
Adjusted EBITDAnon-GAAPFY2026$180.00M – $220.00M–NewMar 19, 2026

Guidance history

Every forecast Alvotech put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 19, 2026Adjusted EBITDAFY2026$180.00M – $220.00MNew
Mar 19, 2026total revenuesFY2026$650.00M – $700.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Alvotech filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?